Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Army
Medtronic
Johnson and Johnson
US Department of Justice
Fish and Richardson

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 8,420,081

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,420,081
Title:Antibody formulations and methods of making same
Abstract: The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductivity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.
Inventor(s): Fraunhofer; Wolfgang (Shrewsbury, MA), Bartl; Annika (Ludwigshafen, DE), Krause; Hans-juergen (Grunstadt, DE), Tschoepe; Markus (Hessheim, DE), Kaleta; Katharina (Ludwigshafen, DE)
Assignee: AbbVie, Inc. (North Chicago, IL)
Application Number:12/325,049
Patent Claims:see list of patent claims

Details for Patent 8,420,081

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up AbbVie, Inc. (North Chicago, IL) 2027-11-30 RX search
Cytogen PROSTASCINT capromab pendetide VIAL; INTRAVENOUS 103608 001 1996-10-28 ➤ Sign Up AbbVie, Inc. (North Chicago, IL) 2027-11-30 RX search
Centocor Inc MYOSCINT imciromab pentetate VIAL 103634 001 1996-07-03 ➤ Sign Up AbbVie, Inc. (North Chicago, IL) 2027-11-30 DISCN search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up AbbVie, Inc. (North Chicago, IL) 2027-11-30 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 001 1998-05-12 ➤ Sign Up AbbVie, Inc. (North Chicago, IL) 2027-11-30 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12 ➤ Sign Up AbbVie, Inc. (North Chicago, IL) 2027-11-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Merck
Chinese Patent Office
Medtronic
QuintilesIMS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.